Copyright
©The Author(s) 2019.
World J Gastroenterol. Feb 7, 2019; 25(5): 608-621
Published online Feb 7, 2019. doi: 10.3748/wjg.v25.i5.608
Published online Feb 7, 2019. doi: 10.3748/wjg.v25.i5.608
Figure 3 Comparison of cumulative survival rates.
Survival rate of intrahepatic bile duct adenocarcinoma group was better than that of sarcomatoid cholangiocarcinoma group.
- Citation: Kim DK, Kim BR, Jeong JS, Baek YH. Analysis of intrahepatic sarcomatoid cholangiocarcinoma: Experience from 11 cases within 17 years. World J Gastroenterol 2019; 25(5): 608-621
- URL: https://www.wjgnet.com/1007-9327/full/v25/i5/608.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i5.608